Trademark: 88873545
Status Date
Tuesday, January 11, 2022
Filing Date
Wednesday, April 15, 2020
Abandoned Date
Tuesday, January 11, 2022
1 Chemical, biological and biochemical products for industrial and scientific purposes, other than for medical purposes, namely, biological tissue cultures for industrial and scientific purposes and not for medical or veterinary purposes; reagents for scientific and research use
9 Downloadable computer software for accessing a database featuring information in the medical field, specifically, stem cell therapy related information; Downloadable software applications for telephones, tablets, computers, namely, software for allowing the access to information and consulting in the field of health; Downloadable software applications for telephones, tablets, computers, namely, software for allowing the access to information, monitoring and management systems for the manufacture of advanced therapy and cell therapy medications; Downloadable databases in the field of manufacture of advanced therapy and cell therapy medications; downloadable electronic publications in the nature of electronic questionnaires on the area of advanced therapy and cell therapy medications; none of the foregoing in the field of pharmaceutical and veterinary products
10 Medical equipment for the manufacturing of autologous and allogeneic biological cell therapies for medical and non-veterinary purposes, namely, fully integrated system for use in the creation of biological cell therapies for medical purposes and disposable single-use containers, namely, bags, pouches, cartridges, rigid and semi-rigid containers for concentrates and solutions in solid or liquid form in the nature of contaminated medical waste for medical use
37 Installation, repair and maintenance services of medical and scientific equipment for the manufacturing of autologous and allogeneic biological cell therapies
40 Custom manufacture of therapeutic drugs by pharmaceutical compounders in the field of cell therapies and cancer therapies; custom manufacturing for others, namely, manufacturing of pharmaceutical and veterinary preparations by pharmaceutical compounders for health care for the treatment of humans and animals suffering from diseases treated by cell therapy or regenerative medicine products, namely, medicines for human purposes, medicines for experimental purposes, biological pharmaceuticals for experimental purposes, pharmaceuticals for cell therapy and medicines for innovative therapies
42 Research and development services in the field of cell therapies; Scientific research in the field of human and animal cell therapy; Providing a bioinformatics platform as a service (PAAS) featuring computer software for sequence data analysis in the field of manufacturing therapeutics; Medical and scientific research information in the field of cell therapy; Medical and scientific research in the field of cell therapy; technical assessments relating to design, namely, technical design consultation in the field of manufacture of advanced therapy and cell therapy medications; Technical research in the field of manufacture of advanced therapy and cell therapy medications; Software as a service (SaaS) services featuring software for assisting in the diagnosis of medical conditions in relation to advanced therapy and cell therapy medications; Cloud computing featuring software for use in assisting in the diagnosis of medical conditions; Providing search engines for the internet in the medical field and manufacturing of advanced therapy and cell therapy medications fields; Computer services, namely, the creation of websites for others used for registered users of virtual communities that allows the organization of groups and events, the participation to discussion, and the involvement into the social, business and community networking in the medical field and manufacturing of advanced therapy and cell therapy medications fields; Computer services, namely, hosting of electronic online web facilities for third parties to organize colloquiums, events and interactive discussions via communication networks in the medical field and manufacturing of advanced therapy and cell therapy medications fields; Hosting digital content for users on the Internet in the medical field and manufacturing of advanced therapy and cell therapy medications fields; Designing web pages for others, namely, online forums in the field of manufacture of advanced therapy and cell therapy
44 Stem cell therapy services; autologous and allogeneic cell therapy services for medical treatment purposes, namely, genetic testing of humans for health assessment, diagnostic or treatment purposes, all for medical purposes; autologous and allogeneic cell therapy services for the treatment of hematological malignancies; medical services, namely, administration of cell therapy services for the treatment of hematological malignancies
Jan 11, 2022
Abandonment Notice Mailed - After Ex Parte Appeal
Jan 11, 2022
Abandonment - After Ex Parte Appeal
Jan 11, 2022
Exparte Appeal Terminated
Nov 29, 2021
Exparte Appeal Dismissed - Failure To File Brief
Sep 29, 2021
Assigned To Examiner
Sep 16, 2021
Notification Of Action Denying Req For Recon E-Mailed
Sep 16, 2021
Action Denying Req For Recon E-Mailed
Sep 16, 2021
Action Continuing Final - Completed
Aug 16, 2021
Teas/Email Correspondence Entered
Aug 16, 2021
Correspondence Received In Law Office
Aug 13, 2021
Assigned To Lie
Aug 10, 2021
Teas Request For Reconsideration Received
Aug 10, 2021
Ex Parte Appeal-Instituted
Aug 10, 2021
Jurisdiction Restored To Examining Attorney
Aug 10, 2021
Exparte Appeal Received At Ttab
Feb 10, 2021
Notification Of Final Refusal Emailed
Feb 10, 2021
Final Refusal E-Mailed
Feb 10, 2021
Final Refusal Written
Jan 11, 2021
Teas/Email Correspondence Entered
Jan 11, 2021
Correspondence Received In Law Office
Jan 11, 2021
Teas Response To Office Action Received
Jul 14, 2020
Notification Of Non-Final Action E-Mailed
Jul 14, 2020
Non-Final Action E-Mailed
Jul 14, 2020
Non-Final Action Written
Jul 6, 2020
Assigned To Examiner
Apr 23, 2020
New Application Office Supplied Data Entered In Tram
Apr 18, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
